Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors

International Journal of Cardiology

Volumn 125, Issue 2, 2008, Pages 172-177

  Setoguchi, Soko ^a   Levin, Raisa ^a   Winkelmayer, Wolfgang C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Angiotensin receptor blockers; Elderly; Heart failure; Trend; Utilization

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; TICLOPIDINE; WARFARIN;

ARTICLE; COMORBIDITY; FEMALE; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEART FAILURE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; PATIENT DISCHARGE; RECEPTORS, ANGIOTENSIN; RESIDENCE CHARACTERISTICS; TIME; TREATMENT OUTCOME;

EID: 40849116254     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.10.009     Document Type: Article

References (26)

1. McCullough P.A., Philbin E.F., Spertus J.A., et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39 1 (2002) 60-69
2. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 18 (2002) 1397-1402
3. American Heart Association. Hospital discharges for cardiovascular diseases (January 19 2006). http://www.americanheart.org/downloadable/heart/1136821961654HospDischarges06.pdf http://www.americanheart.org/downloadable/heart/1136821961654HospDischarges06.pdf
4. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006)
5. Jong P., Vowinckel E., Liu P.P., et al. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 162 15 (2002) 1689-1694
6. Lee V.C., Rhew D.C., Dylan M., et al. Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction. Ann Intern Med 141 9 (2004) 693-704
7. Stafford R.S., Saglam D., and Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 157 21 (1997) 2460-2464
8. Butler J., Arbogast P.G., Daugherty J., et al. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol 43 11 (2004) 2036-2043
9. Masoudi F.A., Rathore S.S., Wang Y., et al. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation 110 6 (2004) 724-731
10. Berger A.K., Duval S., Manske C., et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. Am Heart J 153 6 (2007) 1064-1073
11. Lee D.S., Donovan L., Austin P.C., et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 43 2 (2005) 182-188
12. Birman-Deych E., Waterman A.D., Yan Y., et al. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 43 5 (2005) 480-485
13. Singh J.A., Holmgren A.R., and Noorbaloochi S. Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis. Arthritis Rheum 51 6 (2004) 952-957
14. Winkelmayer W.C., Schneeweiss S., Mogun H., et al. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis 46 2 (2005) 225-232
15. Raiford D.S., Perez Gutthann S., and Garcia Rodriguez L.A. Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database. Epidemiology 7 1 (1996) 101-104
16. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159 7 (2004) 702-706
17. Rangaswamy C., Finn J.I., and Koelling T.M. Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction. Cardiology 103 1 (2005) 17-23
18. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium. Arch Intern Med 157 10 (1997) 1103-1108
19. Vasan R.S., Larson M.G., Benjamin E.J., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 7 (1999) 1948-1955
20. Philbin E.F., and Rocco Jr. T.A. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J 134 2 Pt 1 (1997) 188-195
21. Philbin E.F., Rocco Jr. T.A., Lindenmuth N.W., et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 109 8 (2000) 605-613
22. Hayashida W., Van Eyll C., Rousseau M.F., et al. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: modification by long-term enalapril treatment. The SOLVD Investigators. J Am Coll Cardiol 22 5 (1993) 1403-1410
23. Wachtell K., Bella J.N., Rokkedal J., et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation 105 9 (2002) 1071-1076
24. Klingbeil A.U., Schneider M., Martus P., et al. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 115 1 (2003) 41-46
25. Diez J., Querejeta R., Lopez B., et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105 21 (2002) 2512-2517
26. Konstam M.A. "Systolic and diastolic dysfunction" in heart failure? Time for a new paradigm. J Card Fail 9 1 (2003) 1-3